Statistics for Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial
Total visits
| views | |
|---|---|
| Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial | 54 |
Total visits per month
| views | |
|---|---|
| December 2023 | 0 |
| January 2024 | 2 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
Top country views
| views | |
|---|---|
| United States | 45 |
| China | 2 |
| Germany | 2 |
Top city views
| views | |
|---|---|
| Wilmington | 37 |
| Ann Arbor | 3 |
| Baltimore | 2 |
| Gunzenhausen | 2 |
| Washington | 2 |
| Tustin | 1 |